Regulation/NN
of/IN
Fas/NN
ligand/NN
expression/NN
and/CC
cell/NN
death/NN
by/IN
apoptosis-linked/JJ
gene/NN
4/CD
./.

Programmed/VBN
cell/NN
death/NN
is/VBZ
a/DT
process/NN
required/VBN
for/IN
the/DT
normal/JJ
development/NN
of/IN
an/DT
organism/NN
./.
=====
One/CD
of/IN
the/DT
best/JJS
understood/VBN
apoptotic/JJ
pathways/NNS
occurs/VBZ
in/IN
T/NN
lymphocytes/NNS
and/CC
is/VBZ
mediated/VBN
by/IN
Fas/Fas/NN
ligand/NN
(/(
FasL/NN
)/)
interaction/NN
./.
=====
During/IN
studies/NNS
of/IN
apoptosis/NN
induced/VBN
by/IN
T/NN
cell-receptor/NN
engagement/NN
,/,
we/PRP
identified/VBD
ALG-4F/NN
,/,
a/DT
truncated/VBN
transcript/NN
that/WDT
prevents/VBZ
T/NN
cell-receptor-induced/JJ
FasL/NN
upregulation/NN
and/CC
cell/NN
death/NN
./.
=====
Overexpression/NN
of/IN
full-length/JJ
ALG-4/NN
induced/VBD
transcription/NN
of/IN
FasL/NN
and/CC
,/,
consequently/RB
,/,
apoptosis/NN
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
ALG-4/NN
is/VBZ
necessary/JJ
and/CC
sufficient/JJ
for/IN
FasL/NN
expression/NN
./.
=====
Fas/FasL/NN
interaction/NN
initiates/VBZ
cell/NN
death/NN
in/IN
many/JJ
other/JJ
systems/NNS
,/,
and/CC
its/PRP$
dysregulation/NN
is/VBZ
a/DT
mechanism/NN
by/IN
which/WDT
several/JJ
pathologic/JJ
conditions/NNS
arise/VBP
./.
=====
Understanding/VBG
the/DT
molecular/JJ
mechanisms/NNS
of/IN
FasL/NN
regulation/NN
could/MD
be/VB
very/RB
useful/JJ
in/IN
elucidating/VBG
how/WRB
these/DT
diseases/NNS
develop/VBP
and/CC
in/IN
identifying/VBG
potential/JJ
therapeutic/JJ
targets/NNS
./.